Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

Interactions of herbs with cytochrome P450.

Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW.

Drug Metab Rev. 2003 Feb;35(1):35-98. Review.

PMID:
12635815
3.

Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.

Salminen KA, Meyer A, Jerabkova L, Korhonen LE, Rahnasto M, Juvonen RO, Imming P, Raunio H.

Phytomedicine. 2011 Apr 15;18(6):533-8. doi: 10.1016/j.phymed.2010.08.012. Epub 2010 Sep 20.

PMID:
20851588
4.

In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.

Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Pook PC, Er HM, Ong CE.

J Ethnopharmacol. 2010 Jul 20;130(2):275-83. doi: 10.1016/j.jep.2010.05.002. Epub 2010 May 8.

PMID:
20457244
5.

Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba.

Liu KH, Kim MJ, Jeon BH, Shon JH, Cha IJ, Cho KH, Lee SS, Shin JG.

J Clin Pharm Ther. 2006 Feb;31(1):83-91.

PMID:
16476124
6.

Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions.

Hermann R, von Richter O.

Planta Med. 2012 Sep;78(13):1458-77. doi: 10.1055/s-0032-1315117. Epub 2012 Aug 1. Review.

7.

Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.

Renwick AB, Surry D, Price RJ, Lake BG, Evans DC.

Xenobiotica. 2000 Oct;30(10):955-69.

PMID:
11315104
8.

In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoforms.

Lee HW, Kim DW, Phapale PB, Lim MS, Park J, Seo JJ, Park KM, Park YK, Yoon YR.

J Clin Pharm Ther. 2011 Aug;36(4):496-503. doi: 10.1111/j.1365-2710.2010.01201.x. Epub 2010 Aug 24.

PMID:
21729114
9.

Authentication of the botanical origin of Western herbal products using Cimicifuga and Vitex products as examples.

Masada S.

J Nat Med. 2016 Jul;70(3):361-75. doi: 10.1007/s11418-016-1006-0. Epub 2016 May 17. Review.

10.
11.

Evaluation of metabolism-mediated herb-drug interactions.

Na DH, Ji HY, Park EJ, Kim MS, Liu KH, Lee HS.

Arch Pharm Res. 2011 Nov;34(11):1829-42. doi: 10.1007/s12272-011-1105-0. Epub 2011 Dec 3. Review.

PMID:
22139684
12.

In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.

Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A.

Clin Pharmacol Ther. 2005 May;77(5):415-26.

13.

The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.

Hellum BH, Hu Z, Nilsen OG.

Basic Clin Pharmacol Toxicol. 2007 Jan;100(1):23-30.

14.

Pharmacokinetic interactions between herbal remedies and medicinal drugs.

Ioannides C.

Xenobiotica. 2002 Jun;32(6):451-78. Review.

PMID:
12160480
15.

Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents.

van den Bout-van den Beukel CJ, Koopmans PP, van der Ven AJ, De Smet PA, Burger DM.

Drug Metab Rev. 2006;38(3):477-514. Review.

PMID:
16877262
16.

Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4.

Wanwimolruk S, Wong K, Wanwimolruk P.

Drug Metabol Drug Interact. 2009;24(1):17-35.

PMID:
19353999
17.

The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa).

Huntley A.

Expert Opin Drug Saf. 2004 Nov;3(6):615-23. Review.

PMID:
15500420
18.
19.

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.

Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T.

Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52.

PMID:
10805063
20.

Supplemental Content

Support Center